BRIM BIOTECHNOLOGY

What this record means

The record shows that “BRIM BIOTECHNOLOGY” is a live, registered mark on the Principal Register, owned by BRIM BIOTECHNOLOGY, INC., a corporation organized in Taiwan. It was filed May 12 2017, published Oct 3 2017, and registered Dec 19 2017. The mark covers a wide range of pharmaceutical goods, including medicines for ophthalmic diseases, dermatology, hair loss, osteoarthritis, dengue, zika, infectious diseases, oncology, anti‑cancer preparations, biological preparations for cancer, mixed biological preparations for infectious diseases, and diagnostic test reagents, among others. A similar name used in any of these areas would raise the closest concern. The record does not give the mark control over all uses of the word “biotechnology” or “brim” in unrelated fields. The latest status event is the acceptance of a Section 8 declaration on Jan 31 2024, which keeps the mark active for six years. No opposition, cancellation, or court action appears in the supplied history, so there is no visible enforcement signal. If you’re thinking of a similar name for pharmaceutical products, this record suggests a meaningful risk of conflict.